Table 1.
Clinical data of patients involved in the study and best response to treatment. Numerical variables are expressed as median and inter-quartile range.
| Patients Clinical Data (N = 85) | |
|---|---|
| Age at diagnosis (years) | 63 (57–70) |
| Sex | Female: 17 (20%) |
| Male: 68 (80%) | |
| Performance status | Status 0: 27 (32%) |
| Status 1: 55 (65%) | |
| Status 2: 3 (3%) | |
| PD-L1 expression | Positive: 29 (34%) |
| Negative: 33 (39%) | |
| Unknown: 23 (27%) | |
| HPV status | Positive: 12 (14%) |
| Negative: 12 (14%) | |
| Unknown: 61 (72%) | |
| Type of recurrence | Local: 9 (11%) |
| Regional: 6 (7%) | |
| Loco-regional: 22 (26%) | |
| Distant alone: 19 (22%) | |
| Distant + other: 29 (34%) | |
| Number of lesions | 3 (2–4) |
| Number of affected organs | 2 (1–3) |
| RECIST response | Progressive disease: 55 (65%) |
| Stable disease: 17 (20%) | |
| Partial response: 11 (13%) | |
| Complete response: 1 (1%) | |
| Unknown: 1 (1%) | |